Framework agreement for tafamidis 61 mg capsules

Summary

Amgros I/S is procuring tafamidis 61 mg capsules for Danish hospital pharmacies under a non-exclusive framework agreement. The procurement comprises one contract lot, with an estimated quantity of 33,398 units and an estimated maximum value of DKK 64.1 million. The ordinary purchasing period is 1 May 2027 to 30 April 2028, with options for extension and delivery before or after that period.